EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSSFOG00015029378
Gene Symbol: PTGER4
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSSFOG00015014925
Gene Symbol: LOC108926088
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSSFOG00015003569
Gene Symbol: LOC108924037
3 Cross references
170 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSSFOG00015027210
Gene Symbol: LOC108938021
3 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSSFOG00015010365
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSSFOG00015012832
Gene Symbol: LOC108938933
2 Cross references
210 Possible Orthologues:

Prostaglandin G/h Synthase 2-Like

Ensembl ID : ENSSFOG00015005402
Gene Symbol: LOC108935147
3 Cross references
211 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSFOG00015007014
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSFOG00015001194
Gene Symbol: PTGS1
1 Cross references
210 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSSFOG00015005265
Gene Symbol: PTGS2
3 Cross references
188 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSSFOG00015014611
Gene Symbol: PSMA1
3 Cross references
269 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSSFOG00015005685
Gene Symbol: PSMA2
3 Cross references
266 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).